Ligand-induced changes in surface μ-opioid receptor number: Relationship to G protein activation?

Journal of Pharmacology and Experimental Therapeutics

Volumn 292, Issue 3, 2000, Pages 1127-1134

  Zaki, Paulette A ^a   Keith Jr , Duane E ^a   Brine, George A ^b   Carroll, F Ivy ^b   Evans, Christopher J ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b RTI INTERNATIONAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; CYCLIC AMP; ETORPHINE; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); LIGAND; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; PERTUSSIS TOXIN; TRANSDUCIN;

ARTICLE; BINDING AFFINITY; CELL ACTIVITY; ENZYME ACTIVITY; LIGAND BINDING; POTASSIUM CURRENT; PRIORITY JOURNAL; RECEPTOR BINDING;

ANIMALS; BUPRENORPHINE; CELL LINE; CYCLIC AMP; GTP-BINDING PROTEINS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); MICE; MORPHINE; PERTUSSIS TOXIN; RECEPTORS, OPIOID, MU; UP-REGULATION; VIRULENCE FACTORS, BORDETELLA;

EID: 0034054079     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Adams JU, Paronis CA and Holtzman SG (1990) Assessment of relative intrinsic activity of μ opioid analgesics in vivo by using β-funaltrexamine. J Pharmacol Exp Ther 255:1027-1032.
2. Arden JR, Segredo V, Wang Z, Lameh J and Sadee W (1995) Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged μ opioid receptor expressed in HEK 293 cells. J Neurochem 65:1636-1645.
3. 35S]GTP γ S binding: A tool to evaluate functional activity of a cloned opioid receptor transiently expressed in COS cells. Neurochem Res 21:1301-1307.
4. Belcheva MM, Barg J, McHale RJ, Dawn S, Ho MT, Ignatova E and Coscia CJ (1993) Differential down- and up-regulation of rat brain opioid receptor types and subtypes by buprenorphine. Mol Pharmacol 44:173-179.
5. Bhowmick N, Narayan P and Puett D (1998) The endothelin subtype A receptor undergoes agonist- and antagonist-mediated internalization in the absence of signaling. Endocrinology 139:3185-3192.
6. Boas RA and Villiger JW (1985) Clinical actions of fentanyl and buprenorphine. The significance of receptor binding. Br J Anaesth 57:192-196.
7. Bohm SK, Grady EF and Bunnett NW (1997) Regulatory mechanisms that modulate signaling by G-protein-coupled receptors. Biochem J 322:1-18.
8. Brine GA, Stark PA, Liu Y, Carroll FI, Singh P, Xu H and Rothman RB (1995) Enantiomers of diastereomeric cis-N-[1-(2-hydroxy-2-phenylethyl)-3-methyl-4-piperidyl]-N-phenylpropanamides: Synthesis, X-ray analysis, and biological activities. J Med Chem 38:1547-1557.
9. Burford NT, Tolbert LM and Sadee W (1998) Specific G-protein activation and μ opioid receptor internalization caused by morphine, DAMGO and endomorphin I. Eur J Pharmacol 342:123-126.
10. Chakrabarti S, Yang W, Law PY and Loh HH (1997) The μ opioid receptor down-regulates differently from the δ opioid receptor: Requirement of a high affinity receptor/G protein complex formation. Mol Pharmacol 52:105-113.
11. Davis AM and Inturrisi CE (1999) d-Methadone blocks morphine tolerance and N-methyl-D-aspartate-induced hyperalgesia. J Pharmacol Exp Ther 289:1048-1053.
12. Dhawan BN, Cesselin F, Raghubir R, Reisine T, Bradley PB, Portoghese PS and Hamon M (1996) International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol Rev 48:567-592.
13. Duttaroy A and Yoburn BC (1995) The effect of intrinsic efficacy on opioid tolerance. Anesthesiology 82:1226-1236.
14. Emmerson PJ, Clark MJ, Mansour A, Akil H, Woods JH and Medzihradsky F (1996) Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the μ opioid receptor. J Pharmacol Exp Ther 278:1121-1127.
15. Fantozzi R, Mullikin-Kilpatrick D and Blume AJ (1981) Irreversible inactivation of the opiate receptors in the neuroblastoma x glioma hybrid NG108-15 by chlornaltrexamine. Mol Pharmacol 20:8-15.
16. Ferguson SS, Zhang J, Barak LS and Caron MG (1998) Molecular mechanisms of G protein-coupled receptor desensitization and resensitization. Life Sci 62:1561-1565.
17. Fukuda K, Kato S, Morikawa H, Shoda T and Mori K (1996) Functional coupling of the δ-, μ-, and κ-opioid receptors to mitogen-activated protein kinase and arachidonate release in Chinese hamster ovary cells. J Neurochem 67:1309-1316.
18. Helms JB (1995) Role of heterotrimeric GTP binding proteins in vesicular protein transport: Indications for both classical and alternative G protein cycles. FEBS Lett 369:84-88.
19. Hsieh C, Brown S, Derleth C and Mackie K (1999) Internalization and recycling of the CB1 cannabinoid receptor. J Neurochem 73:493-501.
20. 2-adrenergic receptor desensitization, internalization, and phosphorylation in response to full and partial agonists. J Biol Chem 272:23871-23879.
21. Keith DE, Anton B, Murray SR, Zaki PA, Chu PC, Lissin DV, Monteillet-Agius G, Stewart PL, Evans CJ and Zastrow M (1998) μ opioid receptor internalization: Opiate drugs have differential effects on a conserved endocytic mechanism in vitro and in the mammalian brain. Mol Pharmacol 53:377-384.
22. Keith DE, Murray SR, Zaki PA, Chu PC, Lissin DV, Kang L, Evans CJ and von Zastrow M (1996) Morphine activates opioid receptors without causing their rapid internalization. J Biol Chem 271:19021-19024.
23. Koch T, Schulz S, Schroder H, Wolf R, Raulf E and Hollt V (1998) Carboxyl-terminal splicing of the rat μ opioid receptor modulates agonist-mediated internalization and receptor resensitization. J Biol Chem 273:13652-13657.
24. 2A neuroblastoma cells: Ligand internalization. Br J Pharmacol 120:52-59.
25. Kovoor A, Celver JP, Wu A and Chavkin C (1998) Agonist induced homologous desensitization of μ-opioid receptors mediated by G protein-coupled receptor kinases is dependent on agonist efficacy. Mol Pharmacol 54:704-711.
26. Kurose H, Katada T, Amano T and Ui M (1983) Specific uncoupling by islet-activating protein, pertussis toxin, of negative signal transduction via α-adrenergic, cholinergic, and opiate receptors in neuroblastoma x glioma hybrid cells. J Biol Chem 258:4870-4875.
27. Li JG, Luo LY, Krupnick JG, Benovic JL and Liu-Chen LY (1999) U50,488H-induced internalization of the human κ opioid receptor involves β-arrestin- and dynamin-dependent mechanism. κ Receptor internalization is not required for mitogen-activated protein kinase activation. J Biol Chem 274:12087-12094.
28. Loh HH, Liu HC, Cavalli A, Yang W, Chen YF and Wei LN (1998) μ Opioid receptor knockout in mice: Effects on ligand-induced analgesia and morphine lethality. Brain Res Mol Brain Res 54:321-326.
29. Matthes HWD, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, Befort K, Dierich A, Lemeur M, Dolle P, Tzavara E, Hanoune J, Roques BP and Kieffer BL (1996) Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ opioid-receptor gene. Nature (Lond) 383: 819-823.
30. Ni Q, Xu H, Partilla JS, Stark PA, Carroll FI, Brine GA and Rothman RB (1993) Stereochemical requirements for pseudoirreversible inhibition of opioid μ receptor binding by the 3-methylfentanyl congeners, RTI-46144 and its enantiomers: Evidence for different binding domains. Synapse 15:296-306.
31. Olive MF and Maidment NT (1998) Opioid regulation of pallidal enkephalin release: Bimodal effects of locally administered μ and δ opioid agonists in freely moving rats. J Pharmacol Exp Ther 285:1310-1316.
32. Raynor K, Kong H, Chen Y, Yasuda K, Yu L, Bell GI and Reisine T (1994) Pharmacological characterization of the cloned κ-, δ -, and μ -opioid receptors. Mol Pharmacol 45:330-334.
33. Raynor K, Kong H, Mestek A, Bye LS, Tian M, Liu J, Yu L and Reisine T (1995) Characterization of the cloned human μ opioid receptor. J Pharmacol Exp Ther 272:423-428.
34. Roettger BF, Ghanekar D, Rao R, Toledo C, Yingling J, Pinon D and Miller LJ (1997) Antagonist-stimulated internalization of the G protein-coupled cholecystokinin receptor. Mol Pharmacol 51:357-362.
35. Roth BL and Willins DL (1999) What's all the RAVE about receptor internalization? Neuron 23:629-631.
36. Segredo V, Burford NT, Lameh J and Sadee W (1997) A constitutively internalizing and recycling mutant of the μ-opioid receptor. J Neurochem 68:2395-2404.
37. Selley DE, Breivogel CS and Childers SR (1998) Opioid inhibition of adenylyl cyclase in membranes from pertussis toxin-treated NG108-15 cells. J Recept Signal Transduct Res 18:25-49.
38. Selley DE, Sim LJ, Xiao R, Liu Q and Childers SR (1997) μ Opioid receptor-stimulated guanosine-5′-O-(γ-thio)-triphosphate binding in rat thalamus and cultured cell lines: Signal transduction mechanisms underlying agonist efficacy. Mol Pharmacol 51:87-96.
39. Sora I, Takahashi N, Funada M, Ujike H, Revay RS, Donovan DM, Miner LL and Uhl GR (1997) Opiate receptor knockout mice define μ receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc Natl Acad Sci USA 94:1544-1549.
40. Sternini C, Spann M, Anton B, Keith DE Jr, Bunnett NW, von Zastrow M, Evans C and Brecha NC (1996) Agonist-selective endocytosis of μ opioid receptor by neurons in vivo. Proc Natl Acad Sci USA 93:9241-9246.
41. Szekeres PG, Koenig JA and Edwardson JM (1998) The relationship between agonist intrinsic activity and the rate of endocytosis of muscarinic receptors in a human neuroblastoma cell line. Mol Pharmacol 53:759-765.
42. Thompson AK and Fisher SK (1990) Relationship between agonist-induced muscarinic receptor loss and desensitization of stimulated phosphoinositide turnover in two neuroblastomas: Methodological considerations. J Pharmacol Exp Ther 252: 744-752.
43. Tian M, Broxmeyer HE, Fan Y, Lai Z, Zhang S, Aronica S, Cooper S, Bigsby RM, Steinmetz R, Engle SJ, Mestek A, Pollock JD, Lehman MN, Jansen HT, Ying M, Stambrook PJ, Tischfield JA and Yu L (1997) Altered hematopoiesis, behavior, and sexual function in μ opioid receptor-deficient mice. J Exp Med 185: 1517-1522.
44. Toews ML and Perkins JP (1984) Agonist-induced changes in β-adrenergic receptors on intact cells. J Biol Chem 259:2227-2235.
45. Tolbert LM and Lameh J (1998) Antibody to epitope tag induces internalization of human muscarinic subtype 1 receptor. J Neurochem 70:113-119.
46. 35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Mol Pharmacol 47:848-854.
47. Unterwald EM, Rubenfeld JM, Imai Y, Wang JB, Uhl GR and Kreek MJ (1995) Chronic opioid antagonist administration upregulates μ opioid receptor binding without altering μ opioid receptor mRNA levels. Brain Res 33:351-355.
48. Van Koppen CJ, Sell A, Lenz W and Jakobs KH (1994) Deletion analysis of the m4 muscarinic acetylcholine receptor. Molecular determinants for activation of but not coupling to the Gi guanine-nucleotide-binding regulatory protein regulate receptor internalization. Eur J Biochem 222:525-531.
49. Walker EA, Zernig G and Young AM (1998) In vivo apparent affinity and efficacy estimates for μ opiates in a rat tail-withdrawal assay. Psychopharmacology 136: 15-23.
50. Wang ZX, Zhu YC, Jin WQ, Chen XJ, Chen J, Ji RY and Chi ZQ (1995) Stereoisomers of N-[1-hydroxy-(2-phenylethyl)-3-methyl-4-piperidyl]-N-phenylpropanamide: synthesis, stereochemistry, analgesic activity, and opioid receptor binding characteristics. J Med Chem 38:3652-3659.
51. Whistler JL, Chuang HH, Chu P, Jan LY and von Zastrow M (1999) Functional dissociation of mu opioid receptor signaling and endocytosis: Implications for the biology of opiate tolerance and addiction. Neuron 23:737-746.
52. Whistler JL and von Zastrow M (1998) Morphine-activated opioid receptors elude desensitization by β-arrestin. Proc Natl Acad Sci USA 95:9914-9919.
53. Willins DL, Berry SA, Alsayegh L, Backstrom JR, Sanders-Bush E, Friedman L and Roth BL (1999) Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo. Neuroscience 91:599-606.
54. Yabaluri N and Medzihradsky F (1997) Down-regulation of μ opioid receptor by full but not partial agonists is independent of G protein coupling. Mol Pharmacol 52:896-902.
55. Yu Y, Zhang L, Yin X, Sun H, Uhl GR and Wang JB (1997) μ Opioid receptor phosphorylation, desensitization, and ligand efficacy. J Biol Chem 272:28869-28874.
56. Zadina JE, Kastin AJ, Harrison LM, Ge LJ and Chang SL (1995) Opiate receptor changes after chronic exposure to agonists and antagonists. Ann NY Acad Sci 757:353-361.
57. Zhang J, Ferguson SS, Barak LS, Bodduluri SR, Laporte SA, Law PY and Caron MG (1998) Role for G protein-coupled receptor kinase in agonist-specific regulation of μ opioid receptor responsiveness. Proc Natl Acad Sci USA 95:7157-7162.